Age-related Macular Degeneration Market by Type and Geography - Forecast and Analysis 2021-2025

  • Published: Jun 2021
  • Pages: 120
  • SKU: IRTNTR70644
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The age-related macular degeneration (AMD) market size will grow up to USD 4.00 billion at a CAGR of 5.93% during 2021-2025.

This age-related macular degeneration market analysis report entails exhaustive statistical qualitative and quantitative data on type (wet AMD and dry AMD) and geography (North America, Europe, Asia, and ROW) and their contribution to the target market. View our sample report to gather market insights on the segmentations. Furthermore, with the latest key findings on the post COVID-19 impact on the market, available in this report, you can create successful business strategies to generate new sales opportunities.

What will the Age-related Macular Degeneration Market Size be in 2021?

Browse TOC and LoE with selected illustrations and example pages of Age-related Macular Degeneration Market

 Get Your FREE Sample Now!

Age-related Macular Degeneration Market: Key Drivers and Trends

According to our research output, there has been a neutral impact on the market growth post COVID-19 era. Key drivers such as the high prevalence of AMD are notably supporting the AMD market growth. However, one of the foremost factors impeding market growth is lack of approved therapies for dry AMD. Get detailed insights on the trends and challenges to stay prepared for the obstacles in the future, which will help companies analyze and develop growth strategies.

This post-pandemic age-related macular degeneration market report has assessed the shift in consumer behavior and identified and explored the upcoming trends, drivers, and challenges that will have a far-reaching effect on the market growth. Understanding market trends is essential for identifying new business opportunities across segmentations and geographies.

Who are the Major Age-related Macular Degeneration Market Vendors?

The age-related macular degeneration market forecast report provides insights on complete key vendor profiles and their business strategies to reimage themselves. The leading companies included in the report are as follows:

 

  • AbbVie Inc.
  • Alkeus Pharmaceuticals Inc.
  • Amgen Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Lupin Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.

From our Porter’s five forces analysis study, get detailed insights on the functional involvement of the buyers and suppliers to form well-rounded knowledge about the supply chain and create cost reduction plans. The age-related macular degeneration market analysis report also contains exhaustive observation on the organic and inorganic growth strategies deployed by the vendors. Click here to uncover details of successful business strategies adopted by the vendors.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

For insights on complete key vendor profiles, download a free sample of the age-related macular degeneration market forecast report. The profiles include information on the production, sustainability, and prospects of the leading companies. The report's vendor landscape section also provides industry risk assessment in terms of labor cost, raw material price fluctuation, and other parameters, which is crucial for effective business planning.

Which are the Key Regions for Age-related Macular Degeneration Market?

Age-related Macular Degeneration Market Share by Geography

For more insights on the market share of various regions Request for a FREE sample now!

44% of the market’s growth will originate from North America during the forecast period. The US is a key market for age-related macular degeneration in North America.

North America has been recording significant growth rate and is expected to offer several growth opportunities to market vendors during the forecast period. Strong pipeline and expected approvals have been identified as one of the chief factors that will drive the age-related macular degeneration market growth in North America over the forecast period. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report.

What are the Revenue-generating Type Segments in the Age-related Macular Degeneration Market?

Age-related Macular Degeneration Market Share by Type

To gain further insights on the market contribution of various segments Request for a FREE sample!

The age-related macular degeneration market report provides comprehensive understanding of the subsets of our target market to earmark niche customer groups and simplify demographic requirements. In addition, the report provides insights on the impact of the unprecedented outbreak of COVID-19 on market segments. Through these insights, you can safely deduce transformation patterns in consumer behavior, which is crucial to gauge segment-wise revenue growth during 2021-2025 and embrace technologies to improve business efficiency. The age-related macular degeneration market share growth by the wet AMD segment has been significant and is expected to provide significant growth opportunities to market vendors.

This report provides an accurate prediction of the contribution of all the segments to the growth of the AMD market size. Request for a free sample of the report to get an exclusive glimpse of actionable market insights on post COVID-19 impact on each segment.

Age-related Macular Degeneration Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 6%

Market growth 2021-2025

$ 4.00 billion

Market structure

Fragmented

YoY growth (%)

5.50

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 44%

Key consumer countries

US, Germany, UK, France, and Japan

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

AbbVie Inc., Alkeus Pharmaceuticals Inc., Amgen Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Lupin Ltd., Novartis AG, Pfizer Inc., and Regeneron Pharmaceuticals Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Factors Covered in this Age-related Macular Degeneration Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive age-related macular degeneration market growth during the next five years
  • Precise estimation of the age-related macular degeneration market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the AMD industry across North America, Europe, Asia, and ROW 
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of AMD market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Executive Summary

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Type

  • Market segments
  • Comparison by Type
  • Wet AMD - Market size and forecast 2020-2025
  • Dry AMD - Market size and forecast 2020-2025
  • Market opportunity by Type

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Alkeus Pharmaceuticals Inc.
  • Amgen Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Lupin Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
The age-related macular degeneration market growth will increase by $4003.90 million during 2020-2025.
The age-related macular degeneration market is expected to grow at a CAGR of 5.93% during 2020-2025.
Technavio has segmented the age-related macular degeneration market by type (Wet AMD and Dry AMD) and geographic (North America, Europe, Asia, and ROW).
AbbVie Inc., Alkeus Pharmaceuticals Inc., Amgen Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Lupin Ltd., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc. are a few of the key vendors in the age-related macular degeneration market.
North America will register the highest growth rate of 43.72% among the other regions. Therefore, the age-related macular degeneration market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
The key factors driving the age-related macular degeneration market growth are:
  • High prevalence of AMD
The age-related macular degeneration market vendors should focus on grabbing business opportunities from the wet amd segment as it accounted for the largest market share in the base year.
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>